tiprankstipranks
Trending News
More News >
Cellectis SA (CLLS)
NASDAQ:CLLS

Compare Cellectis SA (CLLS) vs. Competitors

Compare
974 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Cellectis SA
$4.07
$300.52M
-12.21
169.54%
2 Buy
2 Hold
0 Sell
Moderate Buy
Cartesian Therapeutics
$7.42
$191.39M
-0.14
-60.80%
6 Buy
2 Hold
0 Sell
Strong Buy
Foghorn Therapeutics
$6.02
$367.89M
-5.07
43.33%
9 Buy
0 Hold
0 Sell
Strong Buy
Vor Biopharma
$15.75
$308.06M
-0.04
-42.10%
6 Buy
1 Hold
0 Sell
Strong Buy
Tenaya Therapeutics
$1.33
$159.59M
-0.93
-47.55%
8 Buy
0 Hold
0 Sell
Strong Buy
Zura Bio
$4.65
$304.96M
-6.80
167.22%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CLLS
Cellectis SA
4.07
2.56
169.54%
RNAC
Cartesian Therapeutics
7.42
-12.43
-62.62%
FHTX
Foghorn Therapeutics
6.02
1.61
36.51%
VOR
Vor Biopharma
15.75
-11.45
-42.10%
TNYA
Tenaya Therapeutics
0.73
-0.57
-43.92%
ZURA
Zura Bio
4.81
3.02
168.72%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts